<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(1)</volume><submitter>Vetro C</submitter><journal>Blood cancer journal</journal><pagination>181</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12554896</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.</pubmed_title><pmcid>PMC12554896</pmcid><pubmed_authors>Alati C</pubmed_authors><pubmed_authors>Billio A</pubmed_authors><pubmed_authors>Molica M</pubmed_authors><pubmed_authors>Riva C</pubmed_authors><pubmed_authors>Rossi M</pubmed_authors><pubmed_authors>Sperotto A</pubmed_authors><pubmed_authors>Todisco E</pubmed_authors><pubmed_authors>De Luca G</pubmed_authors><pubmed_authors>Lemoli RM</pubmed_authors><pubmed_authors>Memoli M</pubmed_authors><pubmed_authors>Minetto P</pubmed_authors><pubmed_authors>Tanasi I</pubmed_authors><pubmed_authors>Gentile M</pubmed_authors><pubmed_authors>Di Raimondo F</pubmed_authors><pubmed_authors>Pane F</pubmed_authors><pubmed_authors>Grimaldi F</pubmed_authors><pubmed_authors>Venditti A</pubmed_authors><pubmed_authors>Lotesoriere I</pubmed_authors><pubmed_authors>Chiusolo P</pubmed_authors><pubmed_authors>Fianchi L</pubmed_authors><pubmed_authors>Menotti D</pubmed_authors><pubmed_authors>Mule A</pubmed_authors><pubmed_authors>Palumbo GA</pubmed_authors><pubmed_authors>Fili C</pubmed_authors><pubmed_authors>Pagano L</pubmed_authors><pubmed_authors>Romani C</pubmed_authors><pubmed_authors>Perrone S</pubmed_authors><pubmed_authors>Galimberti S</pubmed_authors><pubmed_authors>Martino M</pubmed_authors><pubmed_authors>Salutari P</pubmed_authors><pubmed_authors>Battipaglia G</pubmed_authors><pubmed_authors>Capelli D</pubmed_authors><pubmed_authors>Gottardi M</pubmed_authors><pubmed_authors>Duminuco A</pubmed_authors><pubmed_authors>Martelli MP</pubmed_authors><pubmed_authors>Candoni A</pubmed_authors><pubmed_authors>Isidori A</pubmed_authors><pubmed_authors>Palmieri R</pubmed_authors><pubmed_authors>Palumbo FE</pubmed_authors><pubmed_authors>Cardinali V</pubmed_authors><pubmed_authors>Esposito L</pubmed_authors><pubmed_authors>Guolo F</pubmed_authors><pubmed_authors>Ferrara F</pubmed_authors><pubmed_authors>Marconi G</pubmed_authors><pubmed_authors>Brunetti L</pubmed_authors><pubmed_authors>Vetro C</pubmed_authors><pubmed_authors>Vigna E</pubmed_authors><pubmed_authors>Papayannidis C</pubmed_authors><pubmed_authors>Annunziata M</pubmed_authors><pubmed_authors>Garibaldi B</pubmed_authors><pubmed_authors>Pilo F</pubmed_authors><pubmed_authors>Dargenio M</pubmed_authors><pubmed_authors>Franciosa M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-06T14:34:29.72Z</modification><creation>2026-05-31T03:09:51.848Z</creation></dates><accession>S-EPMC12554896</accession><cross_references><pubmed>41139766</pubmed><doi>10.1038/s41408-025-01394-7</doi></cross_references></HashMap>